Clinical Trials Directory

Trials / Completed

CompletedNCT03403283

Dyslipidemia and Diabetic Retinopathy

Status
Completed
Phase
Study type
Observational
Enrollment
45 (actual)
Sponsor
University of Alabama at Birmingham · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if the reparative cells of blood vessels called endothelial progenitor cells(EPC) are defective in people with diabetes.

Detailed description

The purpose of this study is to determine if the reparative cells of blood vessels, called endothelial progenitor cells (EPC's) are defective in people with diabetes. Diabetic retinopathy (DR) is an eye disease related to diabetes. It can cause blurred vision and possible bleeding in the blood vessels in the back of the eye (retina). Damage to the cells of the blood vessels from DR can cause vision loss or blindness. Even with current treatments, the quality of life for people with DR is much reduced.

Conditions

Interventions

TypeNameDescription
OTHER15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic Retinopathy
OTHERHealthy Controls 15 age matched control subjects

Timeline

Start date
2014-01-01
Primary completion
2023-04-30
Completion
2023-04-30
First posted
2018-01-18
Last updated
2024-05-21
Results posted
2024-05-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03403283. Inclusion in this directory is not an endorsement.